Shattuck Labs, Inc.

Contributing Author

Recent Articles by Shattuck Labs, Inc.

Jun-10	Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering STTK GlobeNewswire
Jun-09	Shattuck Labs, Inc. Announces Proposed Public Offering STTK +9.49% GlobeNewswire
Jun-09	Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update STTK +9.49% GlobeNewswire
Jun-08	Shattuck Labs Announces Phase 1 Results for SL-325 STTK -14.85% GlobeNewswire
Jun-05	Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8 STTK GlobeNewswire
May-07	Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights STTK -6.29% GlobeNewswire
Mar-05	Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights STTK +7.82% GlobeNewswire
Feb-25	Shattuck Labs Announces Participation in Upcoming March Investor Conferences STTK -5.37% GlobeNewswire
Feb-06	Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium STTK +5.60% GlobeNewswire
Dec-15	Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) STTK GlobeNewswire
Nov-20	Shattuck Labs to Participate in Upcoming December Investor Conferences STTK GlobeNewswire
Nov-06	Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights STTK GlobeNewswire
Oct-02	Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel STTK GlobeNewswire
Aug-26	Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors STTK GlobeNewswire
Aug-21	Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease STTK -11.42% GlobeNewswire
Aug-14	Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights STTK +6.13% GlobeNewswire
Aug-05	Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million STTK +33.30% GlobeNewswire
Jul-02	Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism STTK GlobeNewswire
May-01	Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights STTK +9.20% STTK -7.81% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)